JCR Pharmaceuticals
Manufacturing · Japan · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
3-19 Kasuga-cho, Ashiya, Hyogo, 669-6701...Phone Number
+81 797328591Website
www.jcrpharm.co.jpRevenue
$270.1 MillionStock Symbol
4552Industry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About JCR Pharmaceuticals
JCRファーマ株式会社 is a specialty pharmaceutical company focused on rare diseases. They provide biopharmaceuticals and have a strong commitment to research and development. Their intended clients include healthcare professionals, patients and their families, as well as investors and job seekers. The company emphasizes sustainability and corporate governance in its operations.Explore more
JCR Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is JCR Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when JCR Pharmaceuticals launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
JCR Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at JCR Pharmaceuticals
Check out if JCR Pharmaceuticals is spiking on competitors!
Earning: See what the market has to say on JCR Pharmaceuticals recently announced quarterly report
Check if JCR Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Click to see if JCR Pharmaceuticals had a recent Job posting/layoffs
Funding: Get notified immidiatlly once JCR Pharmaceuticals has new funding data
Recommended Actions
Reach out to Masked Content who joined JCR Pharmaceuticals as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
JCR Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
JCR Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about JCR Pharmaceuticals.
JCR Pharmaceuticals Tech Stack
A closer look at the technologies used by JCR Pharmaceuticals
Most Recent Scoops
Project
, according to a high-level source in accounting, is planning to leverage AI-driven automated bookkeeping and data entry over the next six to twelve months.
Automation, Accounting, Financial Reporting, Artificial Intelligence, Finance
Project
, according to a high-level source in accounting, has completed initiatives related to expense tracking within the last twelve months.
Accounting, Financial Planning, Audit, Financial Reporting, Finance
Pain Point
, according to a high-level source in accounting, is experiencing challenges related to accounts receivable.
Pain Point, Accounting, Billing & Invoice, Financial Reporting, Finance
Project
, according to a high-level source in accounting, is planning to begin initiatives related to cash collection automation within six to nine months.
Automation, Accounting, Billing & Invoice, Financial Reporting, Finance
Project
Accounting, Forecasting, Financial Reporting, Artificial Intelligence, Finance
JCR Pharmaceuticals News & Media
JCR Pharmaceuticals Presents Preclinical Gene Therapy Data that Demonstrate Promising CNS Uptake at American Society of Gene and Cell Therapy 28th Annual Meeting
HYOGO, Japan--(BUSINESS WIRE)--JCR announced that the Company presented preclinical data from its novel adeno-associated virus (AAV) gene therapy research programs at ASGCT 2025.Notice of Orphan Drug Designation for JR-446 for Mucopolysaccharidosis Type IIIB by the U.S. FDA
TOKYO & HYOGO, Japan--(BUSINESS WIRE)--MEDIPAL and JCR announced that the U.S. FDA granted orphan drug designation (ODD) to JR-446, an investigational drug for the treatment of MPS IIIB.JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2025 Showcase Research from Its Investigational Treatments for Lysosomal Storage Disorders
HYOGO, Japan--(BUSINESS WIRE)--JCR announced the presentation of two datasets demonstrating the potential benefits of its investigational therapies for LSDs at the WORLDSymposium.JCR Pharmaceuticals to Present at the 21st Annual WORLDSymposium™ 2025
HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals announced today that it will present at the 21st Annual WORLDSymposium 2025, held February 3-7, 2025, in San Diego, Calif.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding JCR Pharmaceuticals
Sign Up For FreeTo access detailed company insights
JCRファーマ株式会社 is a specialty pharmaceutical company focused on rare diseases. They provide biopharmaceuticals and have a strong commitment to research and development. Their intended clients include healthcare professionals, patients and their families, as well as investors and job seekers. The company emphasizes sustainability and corporate governan... Read More
